Skip to main content
Clinical Trials/NL-OMON25012
NL-OMON25012RecruitingNot Applicable

Prevention of cardiovascular disease and progression of renal failure inpatients with chronic renal insufficiency: implementation of maximalendothelial protection with the aid of nurse practitioners. A randomizedmulti-center study.

Not provided0 sites800 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
800

Study Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients are eligible for inclusion when they fulfill the following criteria:
  • 1. The subject is at least 18 years old;
  • 2. The subject is diagnosed with CKD with a creatinine clearance estimated by the Cockcroft-Gault equation between 20 and 70 ml/min;
  • 3. The subject is able and willing to provide written informed consent.

Exclusion Criteria

  • Also none of the exclusion criteria can be present. The following conditions are considered exclusion criteria:
  • 1. A renal transplant less than a year before inclusion;
  • 2. Acute renal failure or rapidly progressive glomerulonephritis established by the treating physician;
  • 3. Any malignancy less than five years before inclusion other than basocellular or squamous cell carcinoma of the skin;
  • 4. Participation in other clinical trials requiring the use of study medication.

Investigators

Sponsor
Not provided

Similar Trials